Modeling our way toward the optimal management of variceal hemorrhage

American Journal of Gastroenterology

Volumn 99, Issue 7, 2004, Pages 1289-1290

  Shah, Vijay ^a   Long, Kirsten H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SUCRALFATE;

DECISION MAKING; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES BLEEDING; HEALTH CARE COST; HUMAN; MODEL; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RECURRENT DISEASE; REVIEW; SECONDARY PREVENTION; TREATMENT OUTCOME; TREATMENT PLANNING; DECISION SUPPORT SYSTEM; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; MULTIMODALITY CANCER THERAPY; NOTE;

COMBINED MODALITY THERAPY; DECISION SUPPORT TECHNIQUES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS;

EID: 3843097242     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40254.x     Document Type: Review

References (10)

1. Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647-55.
2. Lo G, Chen W, Chen M, et al. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002;123:728-34.
3. Patch D, Sabin C, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002;123:1013-9.
4. Lo G, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebieeding: a prospective-randomized trial. Hepotology 2000;32:461-5.
5. Rubenstein J, Eisen G, Inadomi J. A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am J Gastroenterol 2004(in press).
6. Neumann P. Evidence-based and value-based formulary guidelines. Health Aff 2004;23:124-34.
7. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines-similarities, differences and some implications. Value Health 2001;4:225-50.
8. Claxton K, Sculpher M, Drummon M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet 2002;360:711-5.
9. Bosch J, Garcia-Pagan J. Prevention of variceal rebleeding. Lancet 2003;361:952-4.
10. Thalheimer U, Mela M, Patch D, et al. Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: A close look at the evidence. Gut 2004;53:143-8.